Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
Johnson and Johnson
Mallinckrodt
Express Scripts

Last Updated: December 7, 2021

Volunteer for clinical trials for MIFEPREX at ClinicalTrialExchange

DrugPatentWatch Database Preview

MIFEPREX Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Mifeprex, and when can generic versions of Mifeprex launch?

Mifeprex is a drug marketed by Danco Labs Llc and is included in one NDA.

The generic ingredient in MIFEPREX is mifepristone. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mifepristone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mifeprex

A generic version of MIFEPREX was approved as mifepristone by GENBIOPRO on April 11th, 2019.

  Try it Free

Drug patent expirations by year for MIFEPREX
Recent Clinical Trials for MIFEPREX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rochester General HospitalPhase 1
Nova Southeastern UniversityPhase 1
RTI InternationalPhase 1

See all MIFEPREX clinical trials

US Patents and Regulatory Information for MIFEPREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Danco Labs Llc MIFEPREX mifepristone TABLET;ORAL 020687-001 Sep 28, 2000 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MIFEPREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Danco Labs Llc MIFEPREX mifepristone TABLET;ORAL 020687-001 Sep 28, 2000 ⤷  Try it Free ⤷  Try it Free
Danco Labs Llc MIFEPREX mifepristone TABLET;ORAL 020687-001 Sep 28, 2000 ⤷  Try it Free ⤷  Try it Free
Danco Labs Llc MIFEPREX mifepristone TABLET;ORAL 020687-001 Sep 28, 2000 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Dow
Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.